FUTURE-DEVELOPMENTS IN THROMBOLYTIC THERAPY

被引：0
|
作者：
BODE, C [1 ]
RUNGE, MS [1 ]
机构：
[1] EMORY UNIV,SCH MED,DIV CARDIOL,ATLANTA,GA 30322
来源：
ZEITSCHRIFT FUR KARDIOLOGIE | 1993年 / 82卷
关键词：
PLASMINOGEN ACTIVATORS; ANTITHROMBINS; THROMBOLYSIS; ANTIBODY-MEDIATED THROMBOLYSIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A primary failure rate to achieve reperfusion by thrombolytic therapy in acute myocardial infarction of 20-40%, an early reocclusion rate of 5-20%, as well as an increased risk of bleeding that excludes many patients from this form of therapy are today considered main problems. Better application of conventional thrombolytic agents, new conjunctive therapies and development of improved plasminogen activators are investigated with the aim of minimizing these problems.
引用
收藏
页码：187 / 190
页数：4
相关论文
共 50 条
  • [41] Thrombolytic therapy for mitral valve thrombosis
    Lin, TK
    Tsai, LM
    Chen, JH
    Yang, YJ
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1997, 96 (05) : 382 - 385
  • [42] Prehospital thrombolytic therapy in myocardial infarction
    Carlsson, J
    Schuster, HP
    Tebbe, U
    ANAESTHESIST, 1997, 46 (10): : 829 - 839
  • [43] QT Dispersion after Thrombolytic Therapy
    Heris, Saeed Oni
    Rahimi, Behzad
    Faridaalaee, Gholamreza
    Hajahmadi, Mojgan
    Sayyadi, Hojjat
    Naghipour, Bahman
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2014, 8 (04) : 161 - 164
  • [44] Thrombolytic therapy in acute ischaemic stroke
    Thomassen, L
    Waje-Andreassen, U
    Morsund, ÅH
    Hordnes, J
    Maintz, C
    Smievoll, AI
    Russell, D
    CEREBROVASCULAR DISEASES, 2002, 13 (03) : 163 - 167
  • [45] Thrombolytic therapy in patients of female gender
    Vermeer, F
    THROMBOSIS RESEARCH, 2001, 103 : S101 - S104
  • [46] Streptokinase—the drug of choice for thrombolytic therapy
    Adinarayana Kunamneni
    Thaer Taleb Abed Abdelghani
    Poluri Ellaiah
    Journal of Thrombosis and Thrombolysis, 2007, 23 : 9 - 23
  • [47] Rationale for a Nanomedicine Approach to Thrombolytic Therapy
    Lanza, Gregory M.
    Marsh, Jon N.
    Hu, Grace
    Scott, Michael J.
    Schmieder, Anne H.
    Caruthers, Shelton D.
    Pan, Dipanjan
    Wickline, Samuel A.
    STROKE, 2010, 41 (10) : S42 - S44
  • [48] Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction
    Berkowitz, SD
    Granger, CB
    Peiper, KS
    Lee, KL
    Gore, JM
    Simoons, M
    Armstrong, PW
    Topol, EJ
    Califf, RM
    CIRCULATION, 1997, 95 (11) : 2508 - 2516
  • [49] Thrombolytic therapies for ischemic stroke: Triumphs and future challenges
    Moussaddy, Aimen
    Demchuk, Andrew M.
    Hill, Michael D.
    NEUROPHARMACOLOGY, 2018, 134 : 272 - 279
  • [50] COST-BENEFIT-ANALYSIS OF THROMBOLYTIC THERAPY
    HERVE, C
    CASTIEL, D
    GAILLARD, M
    BOISVERT, R
    LEROUX, V
    EUROPEAN HEART JOURNAL, 1990, 11 (11) : 1006 - 1010
12345